Toyota settles lawsuit over 2009 crash in California: report
Saturday, September 18, 2021 12:43 AM

Related Stories

LOS ANGELES, Sep. 18, 2010 (Kyodo News International) -- Toyota Motor Corp. (NYSE:TM) has settled a lawsuit over a fatal crash near San Diego in August last year, which drew widespread attention to sudden acceleration in its cars and led to massive recalls, the Los Angeles Times reported Friday.

The Japanese automaker revealed the settlement in a letter to a California Superior Court judge, but declined to provide any details of the terms, the L.A. Times said in its online edition.

California Highway Patrol officer Mark Saylor was killed along with his wife, daughter and brother-in-law when the Lexus sedan they were traveling in sped out of control and crashed over an embankment. Investigators subsequently said the crash may have been caused by an improperly installed floor mat.

The daily said the suit, filed by Saylor's parents along with the parents of his wife and brother-in-law, was considered by far the strongest among the hundreds of sudden acceleration cases brought against Toyota in the last year.

Bolstered by a 911 recording of the victims screaming ''there's no brakes!'' moments before a fiery death, the accident set off a chain of events leading to congressional hearings, multiple federal investigations and record fines against the automaker, according to the report.



Symbol :


Market news:

  • Congress to send small business bill to Obama Sep 23, 2021 01:37 PM

    • WASHINGTON - A long-delayed bill to help struggling small businesses with easier credit and other incentives to expand and hire new workers is poised to clear its final hurdle.
    • The legislation - slated for a House vote Thursday - would establish a $30 billion government fund to help Main Street banks lend to small businesses.
    • It also would cut taxes on both big and small businesses and boost Small Business Administration loan programs.
      • US restricts, EU bans controversial diabetes pill Sep 23, 2021 01:29 PM

        • European regulators ordered the diabetes drug Avandia off the market and the Food and Drug Administration placed stringent restrictions on its use in the United States, saying heart attack risks associated with the former blockbuster are too great a safety concern to continue its use for most people.
        • The European regulator said it would stop authorizing marketing of Avandia, which will be off the market within the next few months.
        • The FDA said new patients will be able to get a prescription for Avandia, but only if they can't control their blood sugar with other medications.
          • Indian ministers' meeting on games ends Sep 23, 2021 01:24 PM

            • NEW DELHI - An emergency meeting called by the Indian prime minister to take stock of preparations for the Commonwealth Games has ended with no comment from officials.
            • The meeting was attended by India's urban development minister, the sports minister and Delhi's chief minister.
            • NEW DELHI (AP) - Indian officials scrambled Thursday to salvage the rapidly approaching Commonwealth Games as a growing number of competitors delayed their arrival to allow organizers time to finish their frantic preparations.
              • Obama presses for Mideast peace in UN address Sep 23, 2021 12:50 PM

                • UNITED NATIONS - Exhorting world leaders to push past years of cynicism and pessimism, President Barack Obama challenged the countries of the United Nations on Thursday to unite around peace efforts that he said could achieve agreement within a year to create an independent Palestine and a secure Israel.
                • Obama, in a speech to the U.N. General Assembly, urged fellow world leaders to press forward with renewed determination in the quest for Mideast peace, an effort that he acknowledged has encountered "few peaks and many valleys."
                • As Obama spoke, Israel's seat in the hall sat empty because it was a Jewish holiday.
                  • FDA restricts use of controversial diabetes pill Sep 23, 2021 12:27 PM

                    • European health regulators have banned sales of the once-blockbuster diabetes drug Avandia because of evidence it raises the risk of heart attack, but doctors in the U.S. will be able to continue prescribing it with some significant restrictions.
                    • The European regulator said it would stop authorizing marketing of Avandia and said it would be removed from the market within the next few months.
                    • Earlier this month, Britain's drug regulator said an independent panel of experts concluded Avandia raised the risk of heart attacks and recommended it be pulled from the market.

                      More news


    Recent Estimates

AnalystFirm NameSymbolEPS Estimate
gofasterstripesMr Lak CTXS$0.25
anamrdaNA JNJ$1.15